Prompted by the remarkable overlap in ASH2L and CHD1 target genes, we examined their loss-of-function in diverse cancer types and found mutations in CHD1 and histone lysine methyltransferases of the MLL complexes frequently co-occurred. This evidence concerns the gene ASH2L and cancer.